Total Payments
$46,706
2024 Payments
$3,132
Companies
75
Transactions
1,070
Medicare Patients
4,104
Medicare Billing
$532,671
Payment Breakdown by Category
Food & Beverage$26,388 (56.5%)
Other$16,650 (35.6%)
Consulting$3,325 (7.1%)
Travel$184.48 (0.4%)
Education$158.97 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $26,388 | 1,035 | 56.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,650 | 11 | 35.6% |
| Consulting Fee | $3,325 | 6 | 7.1% |
| Travel and Lodging | $184.48 | 5 | 0.4% |
| Education | $158.97 | 13 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $11,170 | 142 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $11,122 | 22 | $0 (2023) |
| Novo Nordisk Inc | $3,179 | 104 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,748 | 76 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,477 | 74 | $0 (2024) |
| Amgen Inc. | $1,864 | 53 | $0 (2024) |
| ABBVIE INC. | $1,699 | 73 | $0 (2024) |
| Lilly USA, LLC | $1,120 | 56 | $0 (2024) |
| Amarin Pharma Inc. | $1,071 | 44 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,026 | 52 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,132 | 88 | ABBVIE INC. ($493.55) |
| 2023 | $2,215 | 63 | GlaxoSmithKline, LLC. ($415.78) |
| 2022 | $2,979 | 94 | Novo Nordisk Inc ($362.50) |
| 2021 | $4,756 | 131 | E.R. Squibb & Sons, L.L.C. ($1,599) |
| 2020 | $1,614 | 84 | AstraZeneca Pharmaceuticals LP ($424.72) |
| 2019 | $8,789 | 190 | PFIZER INC. ($4,531) |
| 2018 | $7,663 | 194 | PFIZER INC. ($3,033) |
| 2017 | $15,558 | 226 | E.R. Squibb & Sons, L.L.C. ($7,860) |
All Payment Transactions
1,070 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $109.82 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Automated insulin delivery system | ||||||
| 11/27/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Bone Health | ||||||
| 11/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.35 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $118.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $8.63 | General |
| Category: Bone Health | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $100.05 | General |
| Category: CELLT | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $119.93 | General |
| Category: Obesity | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Inflammation | ||||||
| 10/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Gastroenterology | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $122.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $7.62 | General |
| Category: Bone Health | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $121.23 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $109.84 | General |
| Category: Cardiology | ||||||
| 08/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $97.21 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,045 | 2,184 | $517,110 | $145,291 |
| 2022 | 22 | 989 | 1,898 | $546,478 | $142,947 |
| 2021 | 19 | 934 | 1,661 | $478,713 | $139,810 |
| 2020 | 19 | 1,136 | 2,203 | $579,013 | $104,622 |
Total Patients
4,104
Total Services
7,946
Medicare Billing
$532,671
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 299 | 710 | $216,275 | $56,757 | 26.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 89 | 575 | $89,744 | $27,379 | 30.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 163 | 163 | $56,297 | $20,701 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 133 | 200 | $45,297 | $11,262 | 24.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 28 | 31 | $21,410 | $6,731 | 31.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 64 | 166 | $19,475 | $6,013 | 30.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 70 | $19,636 | $4,264 | 21.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 26 | $12,971 | $3,523 | 27.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 32 | 32 | $8,440 | $1,957 | 23.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 26 | 43 | $6,907 | $1,873 | 27.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $7,170 | $1,352 | 18.9% |
| 90471 | Administration of vaccine | Office | 2023 | 81 | 85 | $4,469 | $1,271 | 28.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $4,670 | $1,065 | 22.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 20 | $2,624 | $737.68 | 28.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 18 | $1,041 | $274.05 | 26.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 16 | $685.00 | $131.91 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 348 | 994 | $318,417 | $78,763 | 24.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 117 | 117 | $38,577 | $15,111 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 161 | 248 | $56,082 | $14,010 | 25.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 28 | 42 | $29,089 | $8,864 | 30.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 20 | 80 | $12,720 | $3,974 | 31.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 37 | 71 | $20,184 | $3,953 | 19.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 20 | 20 | $10,250 | $3,168 | 30.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $8,456 | $2,412 | 28.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 23 | 43 | $6,948 | $2,012 | 29.0% |
About Dr. Robert Keller, MD
Dr. Robert Keller, MD is a Internal Medicine healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962445346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Keller, MD has received a total of $46,706 in payments from pharmaceutical and medical device companies, with $3,132 received in 2024. These payments were reported across 1,070 transactions from 75 companies. The most common payment nature is "Food and Beverage" ($26,388).
As a Medicare-enrolled provider, Keller has provided services to 4,104 Medicare beneficiaries, totaling 7,946 services with total Medicare billing of $532,671. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Fort Worth, TX
- Active Since 06/14/2006
- Last Updated 09/02/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962445346
Products in Payments
- ELIQUIS (Drug) $21,458
- FARXIGA (Drug) $1,562
- JARDIANCE (Drug) $1,227
- Ozempic (Drug) $1,123
- Vascepa (Drug) $1,071
- Otezla (Drug) $763.70
- VRAYLAR (Drug) $718.39
- TRELEGY ELLIPTA (Drug) $713.32
- Wegovy (Drug) $622.97
- INVOKANA (Drug) $607.21
- EVENITY (Biological) $568.44
- UBRELVY (Drug) $512.61
- SHINGRIX (Biological) $496.16
- ENTRESTO (Drug) $485.84
- RYBELSUS (Drug) $401.33
- BEVESPI AEROSPHERE (Drug) $394.61
- Aimovig (Biological) $344.03
- Tymlos (Biological) $339.07
- QULIPTA (Drug) $320.84
- REXULTI (Drug) $314.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fort Worth
Dr. Saravanan Balamuthusamy, M.d, M.D
Internal Medicine — Payments: $449,579
Internal Medicine $449,579
Stevan Gonzalez, Md, MD
Internal Medicine — Payments: $366,565
Internal Medicine $366,565
Tasneem Ahmed, D.o, D.O
Internal Medicine — Payments: $229,979
Internal Medicine $229,979
Dr. Sanjay Oommen, Md, MD
Internal Medicine — Payments: $56,958
Internal Medicine $56,958
Laura Armas-Kolostroubis, Md, MD
Internal Medicine — Payments: $48,384
Internal Medicine $48,384
Dr. Rohit Puskoor, M.d, M.D
Internal Medicine — Payments: $39,688
Internal Medicine $39,688